Analyst Articles

XORTX Breaking Up the Code with Uric Acid

New 33-page Initiation Equity Research Report on XORTX, with a Speculative Buy rating and one-year price target of $2.30/share. The Company has two potential late stage drugs in development focused on kidney diseases that could initiate pivotal Phase 3 clinical trials in the next 12 months. [more]

Scooters
Analyst Articles

e-Scooter and Micro-Mobility Industry Quarterly Update

In Canada, e-scooter companies Bird, Lime, and Roll launched the first e-scooter pilot in Ontario. However, the micro-mobility industry experienced a major complication as three deaths were reported in the U.S. on mopeds serviced by Revel Transit. [more]

Analyst Articles

New Found Gold Closes $31.4 Million IPO

With a market cap of $200M, New Found Gold closed an IPO financing last week to become the newest listed Newfoundland gold explorer. With a shareholder base that includes Palisades Goldcorp, Eric Sprott, Novo Resources, and Rob McEwen, the Company is focusing on the Queensway project, following up on previous drill results that included 92.9 g/t gold over 19.0 metres. [more]